Skip to main content
GOVX logo

GeoVax Labs, Inc.

GOVXNASDAQHealthcareBiotechnology

$0.24Today:- (-)1Y −98.13%

As of Oct 16, 2026 close

Market cap
$1.18M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.24$15.75
Volume (live)
-
Avg. volume (3M)
697.82K

GeoVax Labs (GOVX) Income Statement

GeoVax Labs reported revenue of $2.49M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 37.1% from $3.95M a year earlier. GeoVax Labs posted a net loss of $21.46M, compared with a net loss of $24.99M a year earlier. Gross margin was 100.0% and operating margin -869.3%.

GeoVax Labs Income Statement Analysis

Values in millions USD

Scroll to see more
GeoVax Labs, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue2.493.950.000.080.391.821.180.961.08
Cost of Revenue18.1223.7120.729.1215.552.440.001.882.02
Gross Profit2.493.95-20.72-9.040.39-0.621.18-0.92-0.94
Operating Expenses
Research & Development18.1223.7120.729.1215.552.441.911.882.02
Selling, General & Administrative6.015.396.024.993.582.201.641.651.23
Operating Expenses24.1329.1026.744.9919.132.203.553.533.25
Operating Income-21.64-25.14-26.74-14.03-18.75-2.82-2.37-2.56-2.17
Other Income/Expense
Interest Income0.170.170.780.010.000.000.010.010.00
Interest Expense0.00-0.020.000.000.00-0.140.000.000.00
Other Income/Expense0.170.150.780.010.18-0.140.000.000.00
Income
Income Before Tax-21.46-24.99-25.97-14.02-18.57-2.96-2.37-2.56-2.17
Income Tax Expense0.000.000.000.000.000.000.000.010.00
Net Income-21.46-24.99-25.97-14.02-18.57-2.96-2.37-2.56-2.17
Net Income - Continuous Operations-21.46-24.99-25.97-14.02-18.57-2.96-2.37-2.56-2.17
Net Income - Discontinued Operations---------
EBITDA-21.57-25.05-25.89-13.96-18.71-2.80-2.36-2.54-2.14
EBIT-21.64-25.14-25.97-14.03-18.75-2.82---
Depreciation & Amortization0.070.100.070.060.040.020.010.020.03
Earnings Per Share
Basic EPS-22.00-120.00-357.00-138.00-1142.00-6420.00-23.00-25.00-21.00
Diluted EPS-22.00-120.00-357.00-138.00-1140.00-29.00-23.00-25.00-21.00
Basic Shares Outstanding0.960.210.070.100.020.000.100.100.10
Diluted Shares Outstanding0.960.210.070.100.020.000.100.100.10

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About GeoVax Labs Financial Statements

What was GeoVax Labs's revenue in fiscal 2025?

GeoVax Labs reported revenue of $2.49M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 37.1% from $3.95M a year earlier.

Is GeoVax Labs profitable?

No. GeoVax Labs reported a net loss of $21.46M in fiscal 2025. In fiscal 2024 it lost $24.99M.

What is GeoVax Labs's operating margin?

GeoVax Labs's operating income was −$21.64M on revenue of $2.49M in fiscal 2025, an operating margin of -869.3%, compared with -635.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition